<DOC>
	<DOCNO>NCT00320489</DOCNO>
	<brief_summary>To compare health outcome patient schizophrenia , risk relapse , treat long act injection form olanzapine versus treatment oral olanzapine .</brief_summary>
	<brief_title>Olanzapine Pamoate Depot Versus Oral Olanzapine Treatment Outcomes Outpatients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Clinical diagnosis schizophrenia Must outpatient ( require hospitalization ) least past 8 week . Disease symptom must meet certain range assess clinician . Patient experience least two episode clinical worsen condition . This could mean admission hospital emergency room visit . This could mean new medication add , medication dose increase , medication switch order well control symptoms condition . The patient must unsatisfactory response current medication experience negative effect current medication always take current medication change current medication desire . Patients actively suicidal . Patients pregnant nursing . Patients stop past treatment olanzapine adverse event , treatment resistant allergic olanzapine , condition would prevent use long acting form olanzapine . Patients uncorrected narrowangle glaucoma , seizure , uncontrolled diabetes , certain disease liver , uncontrolled thyroid condition serious unstable illness . Patients Parkinson 's disease , psychosis relate dementia relate disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>